TABLE 1.
Senolytic class | Active compound(s) | Compound library tested to identify senolytic(s) | Cell model(s) used to identify activity | Ref. |
---|---|---|---|---|
Kinase inhibitors | Dasatinib | 46 manually selected compounds known to target anti‐apoptotic pathways | HUVECs and preadipocytes induced by ionizing radiation | Zhu et al. (2015) |
Nintedanib, R406 | Selleck Chem Kinase Inhibitor Library L1200 (n = 355) | HDFs induced by replicative exhaustion | Cho et al. (2020) | |
Terreic acid a , PD‐98059 a , daidzein a , Y‐27632 a | SCREEN‐WELL® Kinase Inhibitor Library (n = 80) | HUVECs induced by oxidative stress, camptothecin treatment, and replicative exhaustion | Kusumoto et al. (2021) | |
Naturally occurring polyphenols | Quercetin | 46 manually selected compounds known to target anti‐apoptotic pathways | HUVECs and preadipocytes induced by ionizing radiation | Zhu et al. (2015) |
Piperlongumine and analogs BRD4809, PL‐DI, PL‐7 and PL‐FPh | Manually selected compounds with bioactivities related to senescent cell viability | WI‐38 fibroblasts induced by ionizing radiation | Wang et al. (2016) | |
Fisetin | Candidate study/10 flavonoid polyphenols | HUVECs induced by ionizing radiation, Ercc1 −/− MEFs induced by oxidative stress, IMR‐90 fibroblasts induced by etoposide treatment | Yousefzadeh et al. (2018); Zhu et al. (2017) | |
Curcumin | 10 flavonoid polyphenols | Ercc1 −/− MEFs induced by oxidative stress | Yousefzadeh et al. (2018) | |
Curcumin analogs EF24, HO‐3867 and 2‐HBA | Candidate study also tested curcumin analog DIMC | WI‐38 fibroblasts induced by ionizing radiation | Li et al. (2019) | |
o‐vanillin | Candidate study | naturally occurring senescent degenerated nucleus pulposus cells | Cherif et al. (2019) | |
Procyanidin C1 | 46 natural compounds and plant extracts with putative anti‐aging properties | PSC27 prostate stromal cells induced by bleomycin treatment, replicative exhaustion, and oncogenic H‐RAS expression | Xu et al. (2021) | |
Gingerenone A | 4 plant extracts with anti‐inflammatory properties: Cat's claw, Devil's claw, Canadian goldenrod, and ginger | WI‐38 fibroblasts induced by ionizing radiation | Moaddel et al. (2022) | |
Solidago virgaurea subsp. alpestris | Candidate study | HDFs induced by oxidative stress (senolysis observed after a chronic treatment period of 39 days) | Lammermann et al. (2018) | |
Isatis tinctoria extract (active components not analyzed) | Six plant extracts with anti‐inflammatory properties: Isatis tinctoria, Rosmarinus officinalis, Rosa, Prunus persica, Nelumbo nucifera, Citrus unshiu Marcov | HDFs induced by replicative exhaustion | Kim et al. (2022) | |
BCL‐2 family inhibitors | ABT‐263 | 37 manually selected compounds with bioactivities related to senescent cell viability | WI‐38 fibroblasts induced by ionizing radiation | Chang et al. (2016) |
A1331852, A1155463 | Candidate study | HUVECs and IMR‐90 fibroblasts induced by ionizing radiation | Zhu et al. (2017) | |
ABT‐737 | Candidate study | IMR‐90 fibroblasts induced by exhaustive replication, etoposide treatment and oncogenic H‐Ras expression | Yosef et al. (2016) | |
S63845, UM177, AZD5991 | Candidate study | PC3 and LNCaP prostate tumor cells induced by treatment with docetaxel and palbociclib | Troiani et al. (2022) | |
Heat shock protein inhibitors | 17‐DMAG and other HSP90 inhibitors | SCREEN‐WELL® autophagy library (n = 97) | Ercc1 −/− MEFs induced by oxidative stress | Fuhrmann‐Stroissnigg et al. (2017) |
25‐hydroxycholesterol | Candidate study, also tested NCI‐41356 | Fibro‐adipogenic progenitors, satellite cells, and skeletal muscle myoblasts induced by doxorubicin treatment | Limbad et al. (2022) | |
BET family protein degraders | ARV825, I‐BET151, I‐BET762, JQ1, OTX015, PFI‐1 | TAKEDA drug discovery library (n = 47,000) | IMR‐90 fibroblasts induced by oncogenic H‐Ras expression | Wakita et al. (2020) |
JQ1 | Candidate study | HDFs induced via bleomycin treatment | Go et al. (2021) | |
P53 stabilizers | RG‐7112 | Candidate study | Naturally occurring senescent annulus fibrosus and nucleus pulposus cells | Cherif et al. (2020) |
USP7 inhibitors P5091 and P22077 | Candidate study | WI‐38 fibroblasts induced by ionizing radiation and exhaustive replication | He, Li, et al. (2020) | |
Other repurposed anti‐cancer drugs | GL‐V9 | Candidate study | Naturally occurring senescent MDA‐MB‐231 breast cancer cells and MEFs induced by exhaustive replication | Yang, Tian, et al. (2021) |
Panobinostat | Candidate study | A549 lung carcinoma cells induced by paclitaxel and cisplatin treatment | Samaraweera et al. (2017) | |
MitoTam | Candidate study | 4 T1 and MCF7 breast cancer cells induced by doxorubicin treatment, RPE‐1 and HFP‐1 cells induced by BrdU treatment, and BJ fibroblasts induced by exhaustive replication | Hubackova et al. (2019) | |
Cardiac steroids | Bufalin, cinobufagin, convallatoxin, digoxin, digitoxin, ouabain, peruvocide, proscillaridin A | LOPAC and Prestwick libraries of pharmacologically active compounds, GreenPharma and SCREEN‐WELL® natural compound libraries, and one library of venoms and venom‐derived peptides (n = 3742) | IMR‐90 fibroblasts induced by oncogenic H‐Ras expression and etoposide treatment, A549 lung adenocarcinoma cells induced by bleomycin treatment, and SK‐MEL‐103 melanoma cells induced by palbociclib treatment | Guerrero et al. (2019); Triana‐Martinez et al. (2019) |
PPRα agonists | Fenofibrate | Prestwick library of pharmacologically active approved compounds (n = 1120) | T/C‐28a2 chondrocytes induced by treatment with IL‐6 | Nogueira‐Recalde et al. (2019) |
Antibiotics | Azithromycin, roxithromycin | 15 manually selected approved drugs | MRC‐5 and BJ fibroblasts induced by treatment with BrdU | Ozsvari et al. (2018) |
Nigericin | Candidate study | Endometrial and Warton jelly‐derived MSCs induced by oxidative stress, endometrial MSCs induced by exhaustive replication, dental pulp MSCs induced by doxorubicin treatment, A459 lung adenocarcinoma cells induced by etoposide treatment | Deryabin et al. (2022) |
Abbreviations: HDF, human dermal fibroblast; HUVEC, human umbilical vein endothelial cell; MEF, murine embryonic fibroblast; MSC, mesenchymal stem cell.
Senotherapeutic activity identified but not tested specifically for senolytic activity.